OPHIUCHUS TECHNOLOGIES
Ophiuchus Technologies AG is a Swiss regenerative medicine company founded in June 2013 as a spin-out company of the charitable NOVAGENESIS FOUNDATION, which is registered and domiciled in Switzerland. Ophiuchus Technologies is a production and distribution company for a revolutionary new cell therapy, the proprietary regenerative stem cell technology, DrSC® Neural. Over a decade of top-notch research and development conducted in USA and Canada led to the inventions underlying this technolog... y. Utilizing this disruptive technology, Ophiuchus Technologies is addressing a large population of patients that have no other effective treatment option. The product, DrSC® Neural, is developed to treat patients with sub-acute and chronic spinal cord injury and traumatic brain injury, primary progressive MS (PPMS), and ALS/motor neurone disease. DrSC® Neural is the first and only engineered autologous neural stem cell product for true personalised cell replacement of damaged neuronal tissue.
OPHIUCHUS TECHNOLOGIES
Social Links:
Industry:
Biotechnology
Founded:
2013-01-01
Address:
Root, Luzern, Switzerland
Country:
Switzerland
Website Url:
http://www.ophiuchustechnologies.com
Total Employee:
1+
Status:
Closed
Email Addresses:
[email protected]
Official Site Inspections
http://www.ophiuchustechnologies.com
Unable to get host informations!!!
More informations about "Ophiuchus Technologies"
Ophiuchus Technologies - Crunchbase Company Profile & Funding
Ophiuchus Technologies is a production and distribution company for a revolutionary new cell therapy, the proprietary regenerative stem cell technology, DrSC® Neural. Over a decade of …See details»
Ophiuchus Technologies AG - Drug pipelines, Patents, Clinical …
Explore Ophiuchus Technologies AG with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Drug:Neural cell replacement therapy (Ophiuchus Technologies), Autologous …See details»
Ophiuchus Technologies AG - LinkedIn
Ophiuchus Technologies AG | 43 followers on LinkedIn. Ophiuchus Technologies is the first globally to repair the brain and spinal cord by mimicking the salamander’s regeneration …See details»
Organization | Ophiuchus Technologies AG
Ophiuchus Technologies AG Report issue. For profit Phase 2. Founded: Switzerland ... Organization Overview. First Clinical Trial. 2014 NCT02326662. First Marketed Drug. None ...See details»
Ophiuchus Technologies AG Company Profile, Financial and
DigitGaps report on Ophiuchus Technologies AG delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and …See details»
Ophiuchus Technologies AG - startup.ch
Ophiuchus Technologies AG: Ophiuchus Technologies is committed to developing its proprietary regenerative cell technology, DrSC™ Neural in order to provide physicians with a new and …See details»
Ophiuchus Technologies AG - Company Information
Find useful insights on Ophiuchus Technologies AG's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Ophiuchus …See details»
OPHIUCHUS HOLDINGS - Profile, contacts and insights - The Grid
Find key decision-makers, contacts, emails, headcount, share capital, recent funding, IPO status and other insights of OPHIUCHUS HOLDINGS.See details»
Neural cell replacement therapy (Ophiuchus Technologies)
Neural cell replacement therapy (Ophiuchus Technologies): a Cell replacements, Neurogenesis stimulants Drug, Initially developed by Ophiuchus Technologies AG, Now, its global highest …See details»
Ophiuchus Technologies AG - Company Profile & Staff Directory
Ophiuchus Technologies is the first globally to repair the brain and spinal cord by mimicking the salamander’s regeneration capacity through its game-changing DrSC™ technology in human …See details»
Ophiuchus Technologies AG:Acquisition,Acquisition Analysis
Discovery Company profile page for Ophiuchus Technologies AG including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Ophiuchus Technologies AG (Ophiuchus Technologies AG) - 药物 …
了解Ophiuchus Technologies AG (Ophiuchus Technologies AG)公司的药物管线，治疗领域，技术平台，以及它的1项临床试，药物:Neural cell replacement therapy (Ophiuchus …See details»
Ophiuchus Technologies AG:Company Profile & Technical …
Ophiuchus Technologies is a company that provides Medicine, Regenerative medicine and more. Ophiuchus Technologies is headquartered in Switzerland Luzern. Ophiuchus Technologies …See details»
Ophiuchus Technologies AG in Liquidation - business-monitor.ch
Ophiuchus Technologies AG in Liquidation (gelöscht), aktiv in "Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin" - …See details»
Ophiuchus Technologies Culture | Comparably
Learn about Ophiuchus Technologies' culture, see what work's like, read reviews, and find job opportunities.See details»
Ophiuchus Technologies AG: Drug pipelines, Patents, Clinical trials ...
Oct 15, 2023 Explore Ophiuchus Technologies AG with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 1 literature, Disease Domain:Nervous System …See details»
Neural cell replacement therapy - Ophiuchus Technologies
Ophiuchus Technologies was developing an autologous neural stem cell product for the treatment of traumatic brain injury and spinal cord injury. The product was Neural cell replacement …See details»
Ophiuchus
Art meets algorithm We believe in the transformative power of collaboration, where ideas flourish and technological frontiers expand. Our journey is about more than just technology; it's about …See details»
Ophiuchus Technologies, Inc. | ICIJ Offshore Leaks Database
Ophiuchus Technologies, Inc. Registered in: Not identified. Linked countries: Antigua and Barbuda, Not identified. Agent: Commonwealth Trust Limited Search in: The Offshore Leaks …See details»
Ophiuchus Technology - Products, Competitors, Financials, …
CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve …See details»